Angiotensin receptor blockers

Angiotensin receptor blockers and the risk of cancer: insights from clinical trials and recent drug recalls

Summarizes clinical trial evidence suggesting a possible link between angiotensin receptor blocker use and cancer, additional clinical evidence tending to refute a link, basic science evidence, and recent information about the problem of potentially cancer-causing impurities found in some angiotensin receptor blocker products.

Hypertension hot potato — anatomy of the angiotensin-receptor blocker recalls

We provide insights into the effects of recent blood pressure medication recalls on patients, healthcare providers, and health systems.